Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.

Completed · Not applicable

Conditions studied: Colorectal Cancer Screening

In brief

The primary objective of this multicenter, prospective, randomized study is to assess the diagnostic yield of Colon Capsule Endoscopy (CCE) versus Computed Tomographic Colonography (CTC) in a screening population.

Key facts

Study ID: NCT02754661
Run by: Medtronic - MITG
People needed: 320
Starts: 2016-09-01
Expected to finish: 2018-08-07
Last updated by the study team: 2019-10-01

Who can join

Age: 50 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Subject is between 50 and 75 years of age (for African Americans only, subject is between 45-75 years of age).
Subject is classified as average risk per the American Gastroenterological Association Guidelines on Colorectal Cancer Screening: Individuals without a personal or family history of CRC or adenomas, inflammatory bowel disease, or high-risk genetic syndromes.
Subject is willing and able to participate in the study procedures and to understand and sign the informed consent.

You may not qualify if…

Subject with history of colorectal cancer or adenoma (including those identified by computed tomography [CT], optical colonoscopy [OC[, sigmoidoscopy, etc.).
Subject with history of negative colonoscopy within 10 years, as these subjects would be defined as not requiring screening in this timeframe. For subjects with alternative screening methods, refer to applicable guidelines.
Subject with currently suspected or diagnosed with hematochezia, melena, iron deficiency with or without anemia, or any other rectal bleeding, including positive fecal occult blood test of any variety.
Subject with any current condition believed to have an increased risk of capsule retention such as suspected or known bowel obstruction, stricture, or fistula.
Subject with current dysphagia or any swallowing disorder.
Subject with current serious medical conditions that would increase the risk associated with CCE, CTC, or colonoscopy that are so severe that screening would have no benefit.
Subject with a cardiac pacemaker or other implanted electromedical device.
Subject expected to undergo MRI examination within 7 days after ingestion of the capsule.
Subject with clinical evidence of renal disease, including clinically significant laboratory abnormalities of renal function within the past 6 months, or at any time in the past if not tested within the last 6 months, defined as creatinine, blood urea nitrogen (BUN), and/or glomerular filtration rate (GFR) outside of the local laboratory reference range.
Subject with a diagnosis of gastroparesis or small bowel or large bowel dysmotility.
Subject with allergies or known contraindication to the medications or preparation agents used in the procedure as described in the relevant instructions for use.
Subject has an estimated life expectancy of less than 6 months.
Subject is considered to be part of a vulnerable population (e.g. prisoners or those without sufficient mental capacity).
Subject is pregnant, suspected pregnant, or is actively breast-feeding. Females of child-bearing potential will be required to provide either a urine pregnancy test or serum pregnancy test as part of the participant's standard of care regardless of their participation in the study (except for subjects who are surgically sterile or are post-menopausal for at least two years).
Subject has participated in an investigational drug or device research study within 30 days of enrollment that may interfere with the subject's safety or ability to participate in this study.

Where it is running

University of South Alabama — Mobile, Alabama, United States
Borland-Groover Clinic — Jacksonville, Florida, United States
Loyola University Medical Center — Chicago, Illinois, United States
Indiana University Hospital — Indianapolis, Indiana, United States
Indianapolis Gastroenterology and Hepatology — Indianapolis, Indiana, United States
Baystate Hospital — Springfield, Massachusetts, United States
Mayo Clinic Rochester — Rochester, Minnesota, United States
Clinical Research Professionals — St Louis, Missouri, United States
NYU — New York, New York, United States
Columbia University — New York, New York, United States
Asheville Gastroenterology Associates — Asheville, North Carolina, United States
Thomas Jefferson University — Philadelphia, Pennsylvania, United States
Virginia Gastroenterology institute — Suffolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.